Abstract Submission – Neuromuscular Study Group

Receipt of abstracts will be acknowledged via email to submitter upon successful submission.
Notification for those abstracts selected for presentation will be sent by July 5, 2024.

The deadline for abstract submissions is June 1, 2024.

Submitter Name*
First Last
Submitter Email*
Enter Email Confirm Email
Is this a NMSG re-submission from this year?
- Yes
- No
How is the abstract being submitted?*
- An investigator-initiated study
- An industry/pharma sponsored study
Poster/Presenter Name*
Poster/Presenter Email*
If chosen for a platform presentation, please provide presenter's name and email address.
Title*
The title of the abstract should be fully informative.
Authors*
The names of all authors should be included in the format as follows:
R. Barohn, M. Hanna*, R.C. Griggs** (Kansas City, KS; London, UK*; Rochester, NY**)
Abstract (250 words or less)*
The abstract must adequately describe the objectives and results of the study so that the quality of work can be evaluated by the Neuromuscular Study Group Planning Committee.
The abstract must include the following components and may be disqualified if not followed:
1. Introduction
2. Objectives (or Case Report)
3. Methods
4. Results
5. Conclusions
The meeting is scheduled for Tarrytown, New York, September 20-22, 2024. If accepted, will you travel to the meeting to present and exhibit a poster? We plan to have some travel funds available for investigator initiated studies.*
- Yes
- No
File*
This may be in the format you would like published in the RRNMF Journal, it must include the authors and 1. Introduction 2. Objectives (or Case Report) 3. Methods 4. Results 5. Conclusions. Upload your abstract as a Microsoft Word document.
Accepted file types: doc, docx, Max. file size: 10 MB.
Captcha